Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: urban (3), residential (24), industrial (50)

Ambulatory care for people with acute leukaemia - patient information

Description: This factsheet explains what ambulatory care is and what it involves in relation to your treatment for acute leukaemia, so you
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Ambulatory-care-for-people-with-acute-leukaemia-3647-PIL.pdf

SETT Centre Clinical Theme Lead EOI 2024

Description: Southampton Emerging Therapies and Technologies (SETT) Clinical Theme Lead: Call for expressions of interest The University of Southampton NHS Foundation Trust
Url: /Media/Southampton-Clinical-Research/Downloads/SETT-Centre-Clinical-Theme-Lead-EOI-2024.pdf

Call for expressions of interest UHS Division C R&D Lead

Description: Call for expressions of interest: UHS Division C R&D Lead UHS Division C and Research and Development (R&D) are
Url: /Media/Southampton-Clinical-Research/Downloads/Call-for-expressions-of-interest-UHS-Division-C-RD-Lead.pdf

NIHR BRC Imaging Network Meeting Abstract Advert

Description: NIHR BRC Imaging Network Meeting – Abstract deadline extended to 19th January National Institute for Health and Care Research (NIHR) Biomedical Research
Url: /Media/Southampton-Clinical-Research/Downloads/NIHR-BRC-Imaging-Network-Meeting-Abstract-Advert.pdf

Cyclophosphamide-Epirubicin-Paclitaxel 21day

Description: Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-EPIRUBICIN-PACLITAXEL Regimen • Breast Cancer – Cyclophosphamide-Epirubicin-Paclitaxel Indication • Neoadjuv
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Cyclophosphamide-Epirubicin-Paclitaxel-21day.pdf

Bevacizumab(15mgkg) Carboplatin Gemcitabine (day1)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (15)-CARBOPLATIN (AUC4)-GEMCITABINE (day 1) This protocol may require funding Regimen • Ovary-Bevaciz
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Bevacizumab15mgkg-Carboplatin-Gemcitabine-day1.pdf

Finance and Performance Reports 2021-22 month 4 July 2021

Description: Report to the Trust Board of Directors Title: Agenda item: Sponsor: Author: Date: Purpose Issue to be addressed: Finance
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2021-Trust-document/Finance-and-performance-reports/Finance-and-Performance-Reports-2021-22-Month-4-July-2021.pdf

Carboplatin (AUC5)-Pegylated Liposomal Doxorubicin (Caelyx)x)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC5) - DOXORUBICIN PEGYLATED LIPOSOMAL (Caelyx) Please note this protocol is ba
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC5-Pegylated-Liposomal-DoxorubicinCaelyxVer1.pdf

Bevacizumab (15) Carboplatin-Paclitaxel (21 day)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (15)-CARBOPLATIN (AUC5)-PACLITAXEL (21 day) Regimen • Cervix-Bevacizumab (15)-Carboplatin (AUC5)-
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Cervical-cancer/Bevacizumab-15-Carboplatin-Paclitaxel-21-day.pdf

Accelerated-Cyclophosphamide-Epirubicin-Paclitaxel(14) Ver1

Description: Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-EPIRUBICIN-PACLITAXELACCELERATED Regimen • Breast Cancer – Cyclophosphamide-Epirubicin-
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Accelerated-Cyclophosphamide-Epirubicin-Paclitaxel-14.pdf

551 to 560 of 1000

Previous … 54 55 56 57 58 … Next